ProMIS Neurosciences Inc. SEC filings PMN
ProMIS Neurosciences Inc. has 373 filings in SEC EDGAR's recent list, going back to Aug 29, 2006. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Apr 2, 2026 | — |
| CORRESP | Letter to the SEC | Mar 31, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2026 | — |
| EFFECT | Filing | Mar 26, 2026 | — |
| CORRESP | Letter to the SEC | Mar 24, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 23, 2026 | — |
| EFFECT | Filing | Sep 10, 2025 | — |
| CORRESP | Letter to the SEC | Sep 8, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 8, 2025 | — |
| EFFECT | Filing | Aug 22, 2025 | — |
| CORRESP | Letter to the SEC | Aug 20, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 20, 2025 | — |
| EFFECT | Filing | Sep 6, 2024 | — |
| CORRESP | Letter to the SEC | Sep 4, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2024 | — |
| EFFECT | Filing | Sep 29, 2023 | — |
| EFFECT | Filing | Sep 29, 2023 | — |
| CORRESP | Letter to the SEC | Sep 27, 2023 | — |
| CORRESP | Letter to the SEC | Sep 27, 2023 | — |
| EFFECT | Filing | Sep 25, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2023 | — |
| EFFECT | Filing | Mar 23, 2023 | — |
| EFFECT | Filing | Nov 9, 2022 | — |
| CORRESP | Letter to the SEC | Nov 8, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2022 | — |
| D | Filing | Oct 21, 2022 | — |
| SEC STAFF LETTER | Filing | Jul 7, 2022 | — |
| SEC STAFF ACTION | Filing | Jul 7, 2022 | — |
| CERT | Form 10 cert | Jul 7, 2022 | — |
| CORRESP | Letter to the SEC | Jul 6, 2022 | — |
| CORRESP | Letter to the SEC | Jul 1, 2022 | — |
| 10-12B/A | Filing | Jul 1, 2022 | — |
| SEC STAFF LETTER | Filing | Jun 30, 2022 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2022 | — |
| 10-12B/A | Filing | Jun 30, 2022 | — |
| CORRESP | Letter to the SEC | Jun 22, 2022 | — |
| 10-12B | Filing | Jun 22, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2022 | — |
| DRSLTR | Filing | Apr 5, 2022 | — |
| DRS/A | Filing | Apr 5, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 28, 2022 | — |
| DRS | Filing | Jan 28, 2022 | — |
| D | Filing | Sep 9, 2021 | — |
| D | Filing | Mar 30, 2021 | — |
| D | Filing | Nov 16, 2020 | — |
| D | Filing | Nov 20, 2019 | — |
| D | Filing | Jan 31, 2019 | — |
| D | Filing | May 3, 2018 | — |
| D/A | Filing | Sep 11, 2017 | — |
| D | Filing | Aug 18, 2017 | — |
| D | Filing | Mar 27, 2017 | — |
| D | Filing | Mar 8, 2017 | — |
| D/A | Filing | Nov 22, 2016 | — |
| D | Filing | Sep 22, 2016 | — |
| D | Filing | Aug 24, 2016 | — |
| D/A | Filing | Jun 15, 2016 | — |
| D | Filing | Apr 14, 2016 | — |
| D | Filing | Aug 17, 2015 | — |
| D | Filing | Jul 24, 2015 | — |
| D | Filing | Nov 3, 2014 | — |
| D | Filing | Mar 13, 2014 | — |
| D | Filing | Feb 11, 2014 | — |
| D | Filing | Jan 22, 2014 | — |
| D | Filing | May 2, 2013 | — |
| D | Filing | Apr 11, 2013 | — |
| D | Filing | Mar 5, 2013 | — |
| D | Filing | May 29, 2012 | — |
| D | Filing | Mar 16, 2012 | — |
| D | Filing | Jan 26, 2012 | — |
| D | Filing | Mar 9, 2011 | — |
| SUPPL | Auto-generated paper document | Oct 27, 2010 | — |
| SUPPL | Auto-generated paper document | Sep 17, 2010 | — |
| SUPPL | Auto-generated paper document | Aug 31, 2010 | — |
| SUPPL | Auto-generated paper document | Jun 21, 2010 | — |
| SUPPL | Auto-generated paper document | Mar 9, 2010 | — |
| SUPPL | Auto-generated paper document | Aug 12, 2009 | — |
| D | Filing | Jun 15, 2009 | — |
| REGDEX | Auto-generated paper document | Jan 21, 2009 | — |
| REGDEX | Auto-generated paper document | Dec 16, 2008 | — |
| SUPPL | Auto-generated paper document | Mar 12, 2008 | — |
| SUPPL | Auto-generated paper document | Oct 29, 2007 | — |
| SUPPL | Auto-generated paper document | Jul 3, 2007 | — |
| SUPPL | Auto-generated paper document | Jun 14, 2007 | — |
| SUPPL | Auto-generated paper document | Apr 2, 2007 | — |
| REGDEX | Auto-generated paper document | Mar 20, 2007 | — |
| SUPPL | Auto-generated paper document | Mar 9, 2007 | — |
| SUPPL | Auto-generated paper document | Feb 27, 2007 | — |
| SUPPL | Auto-generated paper document | Feb 6, 2007 | — |
| 12G3-2B | Auto-generated paper document | Jan 16, 2007 | — |
| REGDEX | Auto-generated paper document | Aug 29, 2006 | — |
Showing 91 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PMN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Canada (Federal Level)
- Headquarters
- Toronto, Ontario, Canada
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1374339
- Former names
- AMORFIX LIFE SCIENCES LTD (until Nov 3, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.